Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Amgn crawled time : 15:20 save search
The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is forecast to grow by $ 2061.88 mn during 2022-2027, accelerating at a CAGR of 7.96% during the forecast period
Published: 2023-03-15 (Crawled : 15:20) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 52K
|
Health Technology
|
| O: 2.62%
H: 0.0%
C: -3.57%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.0%
H: 1.39%
C: 1.02%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.95%
H: 1.05%
C: 0.54%
ADCT | $4.97 6.2% 1.61% 380K
|
Health Technology
|
| O: -0.81%
H: 3.48%
C: -0.82%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -1.09%
H: 1.45%
C: 1.24%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 0.67%
H: 0.67%
C: -2.22%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: -0.08%
H: 2.24%
C: 1.95%
global therapeutics market
Entera Bio Announces FDA’s Acceptance of a Type D Meeting Review to Affirm Design of the Pivotal, Phase 3 Protocol for EB613 PTH Mini Tablets, as the First Oral Osteoanabolic Treatment of Post-Menopausal Osteoporosis
Published: 2023-02-15 (Crawled : 15:20) - globenewswire.com
ENTX | $2.22 8.29% 7.66% 110K
|
Health Technology
|
| O: 2.34%
H: 9.2%
C: 8.45%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: -0.34%
H: 0.14%
C: -0.06%
eb613 treatment meeting review osteoporosis
Immune-Onc Therapeutics Appoints Two New Members to its Board of Directors
Published: 2022-11-08 (Crawled : 15:20) - biospace.com/
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: 2.0%
H: 4.99%
C: 3.48%
therapeutics
Global Gene Therapy Market Report to 2028 - Industry Analysis, Trends, Market Size and Forecasts
Published: 2022-09-23 (Crawled : 15:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 5.45%
H: 0.0%
C: -8.46%
NVSEF | News | $96.0 0.94% 6.88% 52K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.06%
H: 0.39%
C: -0.41%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: -0.44%
H: 0.46%
C: -0.99%
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: -0.17%
H: 0.17%
C: -1.25%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: 0.11%
H: 0.27%
C: -0.45%
global report therapy market
Global Bio-Pharma Market is Expected to reach USD 703.28 Billion by 2027 at 12.5% CAGR, Says Brandessence Market Research
Published: 2022-09-13 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K
|
Health Technology
|
| O: -4.5%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -1.22%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -1.39%
H: 0.31%
C: -1.16%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -1.19%
H: 0.98%
C: -1.44%
XERS | $1.78 0.0% 1.3M
|
Health Technology
|
| O: -4.92%
H: 5.17%
C: 2.87%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.97%
H: 0.16%
C: -0.98%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -2.2%
H: 0.2%
C: -2.32%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -4.29%
research global expected market
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
CRNX G | $44.21 1.77% 1.74% 610K
|
Health Technology
|
| O: 0.66%
H: 1.22%
C: -5.83%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: -0.08%
H: 0.45%
C: -0.13%
ADAP | $1.14 12.87% 9.82% 1.1M
|
Health Technology
|
| O: 1.85%
H: 6.67%
C: 3.03%
treatment therapy cancer market
FDA APPROVES RIABNI™ (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN® (RITUXIMAB), FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: 7.48%
H: 0.45%
C: -4.8%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: -0.32%
H: 0.2%
C: -1.16%
rituxan fda biosimilar
The Gynecology Drugs Market Is To Reach $26 Bn As It Recovers From The COVID-19 Impact
Published: 2022-05-04 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 3.26%
H: 0.0%
C: -3.77%
PKX | News | $71.48 -0.17% 0.0% 89K
|
Non-Energy Minerals
|
| O: 0.38%
H: 2.4%
C: 2.4%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.2%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.79%
H: 0.0%
C: 0.0%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: -0.09%
H: 1.95%
C: 1.52%
covid-19 market drug
Specialty Enzymes Market Size to Reach USD 4,565 Million in 2030 | Advanced Tools to Optimize Pharmaceutical Production and Increasing R&D Funding for Pharma and Biotech Companies are Key Factors Driving Industry Demand, Says Emergen Research
Published: 2022-04-20 (Crawled : 15:20) - prnewswire.com
DD | News | $73.8 -0.15% 0.0% 1.5M
|
Process Industries
|
| O: 0.77%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
pharma research companies biotech funding market
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.